Reprapog (atovaquone proguanil): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Reprapog 250 mg/100 mg Film-coated Tablets

Prophylaxis of Plasmodium falciparum malaria in adults and in children weighing at least 40 kg.

Treatment of acute, uncomplicated Plasmodium falciparum malaria in adults and in children weighing at least 11 kg.

Official guidelines and local information on the prevalence of resistance to antimalarial drugs should be taken into consideration. Official guidelines will normally include WHO and public health authorities' guidelines.

Reprapog 62.5 mg/25 mg Film-coated Tablets

Prophylaxis of Plasmodium falciparum malaria in adults and children weighing 11-40 kg.

Treatment of acute, uncomplicated Plasmodium falciparum malaria in children weighing ≥5 kg and <11 kg.

Official guidelines and local information on the prevalence of resistance to antimalarial drugs should be taken into consideration. Official guidelines will normally include WHO and public health authorities' guidelines.


Route of administration: Oral
Molecule: atovaquone, proguanil

Patients' opinions on Reprapog

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.